跳至主要内容
临床试验/NCT03059121
NCT03059121已完成不适用

Observational Study of Cardiometabolic Risk in HIV Infected Subjects After Initiation of Antiretroviral Therapy: The Cleveland Cardiometabolic Cohort

University Hospitals Cleveland Medical Center1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2016年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
56
试验地点
1
主要终点
Body composition measures

研究概览

简要总结

In this observational study, the investigators will examine the changes in body composition in HIV-infected subjects before and after initiation of HIV treatment, and look at the correlations with changes in cardiometabolic indices such as endothelial function and coronary calcium scoring.

详细描述

The effects of lifestyle factors on body composition changes after antiretroviral therapy (ART) are unknown, and as such, investigators will use this prospective observational cohort to study relationships between lifestyle factors, including diet, physical activity and illicit drug use, with changes in body composition after ART. In addition, the effect of the body fat changes will be correlated to changes in cardiometabolic indices such as endothelial function and coronary calcium scoring.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV-1 infection as documented by any licensed ELISA test kit and confirmed by Western blot at any time prior to study entry. HIV-1 culture, HIV-1 antigen, plasma HIV-1 RNA, or a second antibody test by a method other than ELISA is acceptable as an alternative confirmatory test
  • Provides written informed consent and is capable of reading and comprehending the informed consent
  • Is not currently taking antiretroviral therapy and has never been on such treatments in the past. Exception would be for subjects who had been in the past on ≤30 days cumulative antiretrovirals, as long as these were stopped >6 months prior to study entry
  • Is planning on starting antiretroviral therapy as part of routine clinic care

排除标准

  • Pregnancy or lactation

研究组 & 干预措施

HIV-infected ART-naïve

HIV-infected subjects ≥ 16 years who are ART-naïve starting their first antiretroviral regimen

干预措施: Dual-energy X-ray absorptiometry (Diagnostic Test)

结局指标

主要结局

Body composition measures

时间窗: Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year

Assessed using DEXA (dual energy x-ray absorptiometry) scans which will be quantifying total body fat

次要结局

  • endothelial function measures(Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year)
  • calcium score measures(Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year)
  • Metabolic syndrome(Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year)
  • Resting Energy Expenditure (REE) measures(Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year)
  • central obesity(Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year)
  • Lipids measures(Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year)
  • Fasting plasma glucose measures(Baseline, 6-month, 1 year, 2 year, 3 year, 4 year, 5 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Grace McComsey

Principle Investigator

University Hospitals Cleveland Medical Center

研究点 (1)

Loading locations...

相似试验